Thursday, November 12, 2026

Dollar Index Climbs 0.1% From Three-Year Low as Multi-Year Decline Pauses

The Bloomberg Dollar Spot Index rose 0.1% after hitting its lowest level since 2022, potentially halting a slide that saw the greenback drop 14% against the euro and 7% against sterling in 2025. The reversal comes as traders reassess positioning amid shifting Federal Reserve rate expectations and geopolitical developments including Iran-US nuclear negotiations.

ViaNews Editorial Team

February 24, 2026

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
Dollar Index Climbs 0.1% From Three-Year Low as Multi-Year Decline Pauses
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The Bloomberg Dollar Spot Index gained 0.1% after touching its lowest point since 2022, signaling a possible pause in the greenback's sharp 2025 decline. The dollar fell 14% against the euro and 7% against the British pound through early 2025 as markets priced in Federal Reserve rate cuts while European central banks maintained tighter policy than expected.

Currency volatility returned to global forex markets as traders repositioned after months of dollar shorts. The pound traded at $1.3086, down 0.5% from recent highs, while the euro stood at €1.13 against sterling. Simon Phillips of No1 Currency noted sterling remains under pressure despite year-to-date gains.

Geopolitical factors are complicating currency forecasts across major markets. Progress in Iran-US nuclear deal talks could shift risk sentiment globally, while the upcoming 2026 Federal Reserve leadership transition creates policy uncertainty. Jordan Rochester at Mizuho Bank warned the pound could fall below $1.30 if dollar strength persists.

UK gilt yields climbed 4 basis points to 5.21% for 30-year bonds, the highest since August 1998, pressuring sterling as investors demand higher premiums for British debt. Neil Wilson of Saxo Markets cited fiscal instability risks. Higher yields make dollar assets relatively more attractive to international investors.

Commodity currencies face headwinds from the dollar rebound. WTI crude held near $61 per barrel, but a stronger dollar typically pressures energy markets by raising costs for buyers using other currencies. This dynamic affects oil-importing nations across Asia, Europe and Latin America.

European equity markets advanced despite forex volatility, with the Stoxx 600 reaching a record 583.4 points. The divergence between currency and equity performance suggests investors are separating regional growth prospects from short-term forex swings.

The dollar's 0.1% gain from multi-year lows creates technical support levels that could attract momentum buyers. However, mixed economic data and central bank policy divergence across major economies mean sustained dollar strength remains uncertain.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com